VEGF165 and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo

Langenbeck's Archives of Surgery

Volumn 392, Issue 3, 2007, Pages 305-314

  Wilcke, I ^a,b,f   Lohmeyer, J A ^a   Liu, S ^a,c,d   Condurache, A ^e   Kruger S ^a   Mailander P ^a   Machens, H G ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c WUHAN UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e UNIVERSITY OF LÜBECK   (Germany)

^f Plastische   (Germany)

Author keywords

Angiogenesis; Matrix vascularisation; Protein based therapy; Slow release system; VEGF165 and bFGF

Indexed keywords

FIBRIN GLUE; GROWTH FACTOR; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT VASCULOTROPIN; RECOMBINANT VASCULOTROPIN 165; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ARTIFICIAL SKIN; BILAYER MEMBRANE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG EFFECT; FULL THICKNESS SKIN GRAFT; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN DEFECT; SLOW DRUG RELEASE; VASCULARIZATION;

ANIMALS; CHONDROITIN SULFATES; COLLAGEN; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; ENDOTHELIUM, VASCULAR; FIBRIN; FIBRIN TISSUE ADHESIVE; FIBROBLAST GROWTH FACTOR 2; MICE; MICE, NUDE; NEOVASCULARIZATION, PHYSIOLOGIC; RECOMBINANT PROTEINS; SKIN; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WOUND HEALING;

EID: 34247553746     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-007-0194-1     Document Type: Article

References (28)

1. Kipshidze N, Chekanov V, Chawla P, Shankar LR, Gosset JB, Kumar K, Hammen D, Gordon J, Keelan MH (2000) Angiogenesis in a patient with ischemic limb induced by intramuscular injection of vascular endothelial growth factor and fibrin platform. Texas Heart Inst J 27:196-200
2. Engler DA (1996) Use of vascular endothelial growth factor for therapeutic angiogenesis. Circulation 94:1496-1498
3. Shou M, Thirumurti V, Rajanayagam S, Lazarous DF, Hodge E, Stiber JA, Pettiford M, Elliott E, Shah SM, Unger EF (1997) Effect of basic fibroblast growth factor on myocardial angiogenesis in dogs with mature collateral vessels. J Am Coll Cardiol 29:1102-1106
4. Thompson JA, Anderson KD, DiPietro JM, Zwiebel JA, Zametta M, Anderson WF, Maciag T (1988) Site-directed neovessel formation in vivo. Science 241:1349-1352
5. Machens HG, Berger AC, Mailaender P (2000) Bioartificial skin. Cells tissues. Organs 167:88-94
6. Tompkins RG, Hilton JF, Burke JF, Schoenfeld DA, Hegarty MT, Bondoc CC, Quinby WC Jr, Behringer GE, Ackroyd FW (1989) Increased survival after massive thermal injuries in adults: preliminary report using artificial skin. Crit Care Med 17:734-740
7. Yannas IV, Burke JF (1980) Design of an artificial skin. I. Basic design principles. J Biomed Mater Res 14:65-81
8. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246:1306-1309
9. Sommer A, Brewer MT, Thompson RC, Moscatelli D, Presta M, Rifkin DB (1987) A form of human basic fibroblast growth factor with an extended amino terminus. Biochem Biophys Res Commun 144:543-550
10. Machens HG, Grzybowski S, Bucsky B, Spanholtz T, Niedworok C, Maichle A, Stockelhuber B, Condurache A, Liu F, Egana JT, Kaun M, Mailander P, Aach T (2006) A technique to detect and to quantify fasciocutaneous blood vessels in small laboratory animals ex vivo. J Surg Res 131:91-96
11. Fam NP, Verma S, Kutryk M, Stewart DJ (2003) Clinician guide to angiogenesis. Circulation 108:2613-2618
12. Koolwijk P, van Erck MG, de Vree WJ, Vermeer MA, Weich HA, Hanemaaijer R, van HV (1996) Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix. Role of urokinase activity. J Cell Biol 132: 1177-1188
13. Kim WJ (2000) Cellular signaling in tissue regeneration. Yonsei Med J 41:692-703
14. Pierce GF, Mustoe TA (1995) Pharmacologic enhancement of wound healing. Annu Rev Med 46:467-481
15. Wong C, Inman E, Spaethe R, Helgerson S (2003) Fibrin-based biomaterials to deliver human growth factors. Thromb Haemost 89:573-582
16. Elcin YM, Dixit V, Gitnick G (2001) Extensive in vivo angiogenesis following controlled release of human vascular endothelial cell growth factor: implications for tissue engineering and wound healing. Artif Organs 25:558-565
17. Carmeliet P (2005) VEGF as a key mediator of angiogenesis in cancer. Oncology 69(Suppl 3):4-10
18. Machens HG, Spanholtz T, Maichle A, Niedworok C, Lindenmaier W, Herbort-Brand S, Görg G, Kropf K, Stöcklhuber B, Reichert B, Siemers F, Krapohl B, Mailaender P (2003) Ein neues gentechnologisches Modell zur Angiogeneseinduktion mittels ex vivo transfizierter isogener Fibroblasten. Chir Forum Exp Klin Forsch 32:237-240
19. Boontheekul T, Mooney DJ (2003) Protein-based signaling systems in tissue engineering. Curr Opin Biotechnol 14:559-565
20. Lutolf MP, Hubbell JA (2005) Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nat Biotechnol 23:47-55
21. Bauters C, Asahara T, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM (1995) Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor. J Vasc Surg 21:314-324
22. Tsurumi Y, Takeshita S, Chen D, Kearney M, Rossow ST, Passeri J, Horowitz JR, Symes JF, Isner JM (1996) Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion. Circulation 94:3281-3290
23. Pepper MS, Ferrara N, Orci L, Montesano R (1992) Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 189:824-831
24. Asahara T, Bauters C, Zheng LP, Takeshita S, Bunting S, Ferrara N, Symes JF, Isner JM (1995) Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92:II365-II371
25. Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J (2004) Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res 94:664-670
26. Kondoh K, Koyama H, Miyata T, Takato T, Hamada H, Shigematsu H (2004) Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. Cardiovasc Res 61:132-142
27. Cao R, Brakenhielm E, Pawliuk R, Wariaro D, Post MJ, Wahlberg E, Leboulch P, Cao Y (2003) Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9:604-613
28. Kano MR, Morishita Y, Iwata C, Iwasaka S, Watabe T, Ouchi Y, Miyazono K, Miyazawa K (2005) VEGF-A and FGF-2 synergistically promote neoangiogenesis through enhancement of endogenous PDGF-B-PDGFRbeta signaling. J Cell Sci 118:3759-3768